NRAS and acute myeloid leukemia: In addition, primary and secondary AML share the same pool of mutational targets, yet the frequencies of mutations in FLT3, PTPEN11, NRAS, NPM1, IDH1, and IDH2 are more prevalent in AML compared to MDS (4, 56).